InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-07-10 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
No financial data available for OPHLY.
Company may not file with SEC or CIK is unresolved.
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight
Ono Pharmaceutical Co., Ltd. (OPHLY) Analyst/Investor Day - Slideshow
Why Ionis Pharmaceuticals’ (IONS) 2026 Catalyst Pipeline Supported Leerink’s Higher Target
Ono Pharmaceutical (TSE:4528) Valuation Check As New Neurology And Rare Disease Partnerships Advance
Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders
Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs
Needham Lifts PT on Ionis Pharmaceuticals (IONS) to $103 From $90
Pfizer wins full FDA approval for Braftovi in colorectal cancer
Pfizer says cancer therapy Braftovi improved survival in late-stage trial
Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation
Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript